Kadmon Corporation to Present at the J.P. Morgan Healthcare Conference
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 01/03/12 -- Kadmon Corporation, LLC today announced that Samuel D. Waksal, Ph.D., Chairman and Chief Executive Officer of Kadmon, will present at the 30th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11th, 2012 at 1:30 p.m. Pacific Time at the Westin St. Francis Hotel in San Francisco. Dr. Waksal will provide an overview of the Company and its commercial and clinical programs.
A live audio webcast of the presentation will be accessible through Kadmon's website at . The webcast will be archived for 90 days.
Kadmon Corporation, LLC is a global biopharmaceutical company built on a 21st-century paradigm for the translation of innovative science into treatment. The company currently offers products and services for the treatment and management of hepatitis C. Kadmon is pioneering medicines in oncology, infectious diseases, immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. For more information, visit .
For Kadmon Corporation:
David Pitts
Argot Partners
212.600.1902
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 03.01.2012 - 13:00 Uhr
Sprache: Deutsch
News-ID 100517
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Healthcare
Diese Pressemitteilung wurde bisher 155 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Kadmon Corporation to Present at the J.P. Morgan Healthcare Conference"
steht unter der journalistisch-redaktionellen Verantwortung von
Kadmon Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
